Fig. 1.
Fig. 1. Survival of patients after allogeneic SCT from the time imatinib mesylate therapy was initiated.

Survival of patients after allogeneic SCT from the time imatinib mesylate therapy was initiated.

Close Modal
This Feature Is Available To Subscribers Only

or Create an Account

Close Modal
Close Modal